Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Overview of attention for article published in The Lancet, August 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 74 news outlets
blogs: 9 blogs
policy: 2 policy sources
twitter: 2332 X users
patent: 7 patents
facebook: 5 Facebook pages

wikipedia: 2 Wikipedia pages
reddit: 7 Redditors
guideline: 3 clinical guideline sources
bluesky: 2 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 366 Mendeley

So far, Altmetric has seen 2723 X posts from 2332 X users, with an upper bound of 9,958,463 followers.

@craigkellyAFEE Early treatment ignored ... Principle Trial - Oxford University So successful they stopped the trial due to ethical reasons. https://t.co/HarUPdfwcO https://t.co/drLNPAzSvT

@alexandrosM Why didn't you show this part of the data? You know where the vaccine appears to amplify the effects of your wonder drug. You must love covid vaccines now right? 🤣🤣🤣🤣 https://t.co/8tLbQkQn9P https://t.co/3n0wzjUgM2

Covid-19 early treatment University of Oxford Principle Trials 2021 https://t.co/HarUPdfwcO https://t.co/vp7YDPXOGr

Covid-19 early treatment University of Oxford Principle Trials https://t.co/HarUPdfwcO https://t.co/XVdjbfgVvC

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2719 additional X posts.